Desk›Healthcare› Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd
BSE 524632 · NSE SHUKRAPHAR · ISIN INE551C01044 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹44.25
+0.05%
BSE close, 28 August 2026
₹1,945.29 cr
44.0 cr shares · Micro cap
₹953.62 cr
as published
54.0× · 35.98×
EPS ₹0.82 · BV ₹1.23
56.71 / 22.05
₹ cr, as filed
25
2 selected · 8%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -32.2% |
|---|---|
| Against 52-week low | +75.5% |
| Day change | +0.05% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹0.82 |
|---|---|
| Price / earnings | 53.96× |
| Price / book | 35.98× |
| Book value — derived, price ÷ P/B | ₹1.23 |
| Return on equity | 66.40% |
| Operating margin | 92.45% |
| Net margin | 63.90% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 66.68%
- ROE as published
- 66.40%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 23.52 | 15.03 | 0.34 | 92.45% | 63.90% |
| Mar-26 · Q | 6.30 | -1.73 | -0.04 | 25.92% | -27.40% |
| FY25-26 | 56.71 | 22.05 | 0.50 | 58.74% | 38.88% |
Quarter on quarter
- Revenue, quarter on quarter
- +273.3%
- Net profit, quarter on quarter
- +968.8%
- Operating margin, quarter on quarter
- +6,653 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| General | 6 |
| AGM / EGM | 3 |
| Board Meeting | 3 |
| Newspaper Publication | 3 |
| Postal Ballot | 3 |
| Outcome | 2 |
| Clarification | 1 |
| Corporate Action | 1 |
| Trading Window | 1 |
| Procedural sub-total | 23 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 2 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-09-022026-10-06
SelectedProcedural
Filings
25 in the window · 9 earlier on record
-
6 October 2026 ·
Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
Allotment of Shares pursuant to conversion of Warrants
Others / Outcome without intimation View filing →
-
6 October 2026 ·
Clarification From The Company
Clarification from the Company
Company Update / General View filing →
-
6 October 2026 ·
Clarification sought from Shukra Pharmaceuticals Ltd
The Exchange has sought clarification from Shukra Pharmaceuticals Ltd on October 06, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
Company Update / Clarification
-
29 September 2026 ·
Voting Results With Scrutinizer Report
Voting Results with Scrutinizer Report
AGM/EGM / Postal Ballot View filing →
-
29 September 2026 ·
Voting Results And Scrutinizer's Report
Voting Results and Scrutinizer's Report
AGM/EGM / AGM View filing →
-
28 September 2026 ·
-
24 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
-
22 September 2026 ·
Corrigendum To Postal Ballot Notice
Corrigendum to Post Ballot Notice
AGM/EGM / Postal Ballot View filing →
-
3 September 2026 ·
-
3 September 2026 ·
Dividend Updates
Intimatation of Record Date for Dividend
Corp Action / Dividend Updates View filing →
-
2 September 2026 ·
Board Meeting Outcome for Allottment Of Preference Shares
Allottment of Preference Shares
Others / Outcome without intimation View filing →
-
31 August 2026 ·
-
27 August 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
AGM/EGM / Postal Ballot View filing →
-
17 August 2026 ·
-
17 August 2026 ·
Board Meeting Intimation for AGM
Shukra Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2026 ,inter alia, to consider and approve AGM
Board Meeting / Board Meeting View filing →
-
14 August 2026 ·
-
14 August 2026 ·
Reg 30 Change Of Name In Object
Reg 30 Change of name in object
Company Update / General View filing →
-
14 August 2026 ·
-
14 August 2026 ·
-
13 August 2026 ·
-
12 August 2026 ·
Quarterly Results June 30, 2026
Quarterly Results June 30, 2026
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Quartely Results June 30, 2026
Quartely results June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
6 August 2026 ·
Update on board meeting
The Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026 Date of Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026
Board Meeting / Board Meeting View filing →
-
30 July 2026 ·
Board Meeting Intimation for Quarterly Results
Shukra Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve To consider and approve ....
Board Meeting / Board Meeting View filing →
RSS feed for Shukra Pharmaceuticals Ltd · the 50 most recent filings